Head-to-Head

Akari Therapeutics plc ADR (0.01 USD) vs. Eli Lilly & Co.

AKTX

Akari Therapeutics plc ADR (0.01 USD)

$6.51 -12.62%

VS LLY

Eli Lilly & Co.

$1427.28 -0.70%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AKTXLLY
Market Cap $14.88 million $1.27 trillion

LLY leads on 1 of 1 size & scale factors.

Dividend

AKTXLLY
Dividend Yield — 0.48%

AKTX and LLY split the dividend factors evenly.

Risk & Sentiment

AKTXLLY
Short Interest 25.74% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: AKTX overview, AKTX financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.